Clinical Trials Directory

Trials / Terminated

TerminatedNCT02925676

Evaluation of the Hypoglycaemia Notification Device Hyposafe H02

Evaluation of the Hypoglycaemia Notification Device Hyposafe H02 - the Pilot 2 Study - in Subjects With Type 1 Diabetes

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
UNEEG Medical A/S · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To evaluate the technical performance of the hyposafe H02 during everyday activities and during insulin-induced hypoglycaemia, in addition to safety issues associated with the implantation and use of the hyposafe H02 in subjects with type 1 diabetes.

Detailed description

While a finger prick test accurately measures the blood glucose level, it does not provide continuous measurements and hence it is unreliable as a hypoglycaemia notification. Recent studies have indicated that the use of continuous glucose monitoring (CGM) reduces the risk of severe hypoglycaemia. However, some find these devices troublesome to use and are annoyed by the inaccuracy of the measurements and even after short-term use the coverage in subgroups of patients is as low as 50% of the time. Thus, there is a medical need for a reliable hypoglycaemia notification which is easy and convenient to use and with high sensitivity and high rate of positive prediction. This clinical investigation is designed to evaluate the sensitivity and the positive predictive value of the Hyposafe H02 in subjects with type 1 diabetes during everyday activities and during insulin-induced hypoglycaemia. In addition, the investigation provides information regarding safety and usability of the device. This to verify that the Hyposafe H02 works as intended in subjects with type 1 diabetes before proceeding with a larger study in subjects with type 1 diabetes.

Conditions

Interventions

TypeNameDescription
DEVICEhyposafe H02hypoglycaemia notification device

Timeline

Start date
2016-10-05
Primary completion
2018-08-29
Completion
2018-09-10
First posted
2016-10-06
Last updated
2024-07-26
Results posted
2024-07-26

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02925676. Inclusion in this directory is not an endorsement.

Evaluation of the Hypoglycaemia Notification Device Hyposafe H02 (NCT02925676) · Clinical Trials Directory